Brokerages expect Healthequity Inc (NASDAQ:HQY) to post sales of $74.12 million for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Healthequity’s earnings. The highest sales estimate is $75.14 million and the lowest is $73.23 million. Healthequity posted sales of $60.44 million in the same quarter last year, which suggests a positive year-over-year growth rate of 22.6%. The business is expected to announce its next quarterly earnings report after the market closes on Wednesday, February 6th.
On average, analysts expect that Healthequity will report full year sales of $285.55 million for the current year, with estimates ranging from $284.00 million to $286.61 million. For the next fiscal year, analysts forecast that the business will post sales of $338.52 million, with estimates ranging from $336.04 million to $345.69 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research firms that that provide coverage for Healthequity.
Healthequity (NASDAQ:HQY) last announced its earnings results on Tuesday, December 4th. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02. Healthequity had a net margin of 24.52% and a return on equity of 12.42%. The business had revenue of $70.50 million for the quarter, compared to analyst estimates of $69.60 million. During the same period last year, the firm posted $0.17 earnings per share. The company’s revenue for the quarter was up 24.1% compared to the same quarter last year.
In other news, VP Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction that occurred on Thursday, December 20th. The shares were sold at an average price of $60.28, for a total value of $241,120.00. Following the transaction, the vice president now owns 82,000 shares in the company, valued at $4,942,960. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Frank Corvino sold 1,778 shares of the company’s stock in a transaction that occurred on Monday, December 10th. The stock was sold at an average price of $67.78, for a total transaction of $120,512.84. Following the completion of the transaction, the director now owns 5,051 shares in the company, valued at approximately $342,356.78. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 11,846 shares of company stock valued at $751,308. Insiders own 4.00% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of the company. FMR LLC lifted its position in Healthequity by 26.5% in the second quarter. FMR LLC now owns 3,410,542 shares of the company’s stock valued at $256,132,000 after buying an additional 715,441 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in Healthequity in the 2nd quarter valued at approximately $586,000. Advisors Asset Management Inc. grew its holdings in Healthequity by 57.4% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,136 shares of the company’s stock valued at $160,000 after buying an additional 779 shares during the last quarter. United Services Automobile Association grew its holdings in Healthequity by 7.1% in the 2nd quarter. United Services Automobile Association now owns 8,298 shares of the company’s stock valued at $623,000 after buying an additional 548 shares during the last quarter. Finally, Nisa Investment Advisors LLC grew its holdings in Healthequity by 10,121.4% in the 3rd quarter. Nisa Investment Advisors LLC now owns 22,487 shares of the company’s stock valued at $2,123,000 after buying an additional 22,267 shares during the last quarter. Hedge funds and other institutional investors own 94.07% of the company’s stock.
Shares of HQY stock traded up $0.64 on Friday, reaching $77.74. 333,953 shares of the company were exchanged, compared to its average volume of 964,259. The stock has a market capitalization of $4.81 billion, a PE ratio of 143.96, a price-to-earnings-growth ratio of 2.52 and a beta of 1.64. Healthequity has a one year low of $47.33 and a one year high of $101.58.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Article: How a Back-End Load Mutual Fund Works
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.